News

To bridge that gap, NASA is partnering with Google to test an A.I. medical assistant for long-duration missions. Known as the ...
In a quiet corner of the biomedical research world, where scientists peer into thousands of time-lapse microscopic images to ...
On Friday, President Donald Trump signed an executive order that would shift power over grantmaking away from career ...
Alzheimer’s is one of the biggest killers in the UK, and as of yet there is no cure. However, early medical trials of a new ...
Except, that future is the present. A company called Recursion Pharmaceuticals (NASDAQ: RXRX) is doing it. Using its access to 65 petabytes' (65 million gigabytes) worth of biological, chemical, and ...
Human monoclonal antibodies targeting rabies glycoprotein have been proposed as a potential alternative to rabies immunoglobulin to neutralise rabies virus at the wound site until sufficient virus ...
The RESONATE-2 trial reveals ibrutinib's long-term efficacy and safety in treating CLL/SLL, especially for high-risk patients ...
First, data and digital business services company, has been recognised as a Major Contender in Everest Group’s Life Sciences Digital Services PEAK Matrix® Assessment 2025. This recognition reflects ...
In this week’s edition of InnovationRx, we look at a biotech entrepreneur treating a rare genetic disease, new tech aimed at ...
Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...
Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive surprises than negative ones.